Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Clinical Features and Possible Mechanisms in Patients With Sarcopenia in Parkinson's Disease
Authors not listed
Central South University · 2024
Abstract
Parkinson\'s Disease (PD) and sarcopenia are prevalent age-related syndromes, often occurring simultaneously within individuals. Sarcopenia is notably common among PD patients, with severe cases affecting approximately one in every five individuals with PD. Moreover, sarcopenia is closely linked to the accelerated progression of PD, diminished quality of life, heightened mortality risk, and increased susceptibility to falls and fractures. Therefore, early detection of sarcopenia assumes particular significance as it offers an opportunity for interventions aimed at mitigating or delaying muscle degeneration, potentially influencing PD outcomes. This review will delve into the relationship between sarcopenia and PD, methods for screening and testing sarcopenia, and potential avenues for further research and the development of strategies for risk reduction and treatment
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
Anonymous. (2024). Clinical Features and Possible Mechanisms in Patients With Sarcopenia in Parkinson's Disease. <em>Central South University</em>. https://clinicaltrials.gov/study/NCT06511531
Vancouver
Anonymous. Clinical Features and Possible Mechanisms in Patients With Sarcopenia in Parkinson's Disease. Central South University. 2024.
BibTeX
@misc{anon2024Clinic,
title = {Clinical Features and Possible Mechanisms in Patients With Sarcopenia in Parkinson's Disease},
author = {Anonymous},
journal = {Central South University},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Institute of Oncology Ljubljana 2023
Open access · US-GOV
Evaluation of the Proportion of Patients With Gastrointestinal Cancer Who Have Symptoms of Sarcopenia
Frontiers in Bioscience-Landmark 2025
Open access · CC-BY
Molecular Pathogenesis of Sarcopenia: Regulatory Networks Involving MicroRNAs in Age-Related Skeletal Muscle Decline
Dokuz Eylul University 2023
Open access · US-GOV
Evaluation of Sarcopenia and Associated Factors in Patients With Lipedema
Neurochemistry International 2026
Citation only
Is Urolithin A(UA) a pharmacologically credible neuro-nutraceutical? A critical review of mechanisms, brain exposure, and evidence gaps in Alzheimer's and Parkinson's disease
Zeitschrift für Gerontologie und Geriatrie 1999
Citation only
Sarcopenia, hypermetabolism, and aging
Circulation 2023
Open access · CC-BY